These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 752854)

  • 1. Chemoimmunotherapy for advanced ovarian carcinoma with adriamycin-cyclophosphamide +/- BCG: early report of a Southwest Oncology Group study.
    Alberts DS; Salmon SE; Moon TE
    Recent Results Cancer Res; 1978; 68():160-5. PubMed ID: 752854
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized study of chemoimmunotherapy for advanced ovarian carcinoma: a preliminary report of a Southwest Oncology Group study.
    Alberts DS; Moon TE; Stephens RA; Wilson H; Oishi N; Hilgers RD; O'Toole R; Thigpen JT
    Cancer Treat Rep; 1979 Feb; 63(2):325-31. PubMed ID: 376137
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stage III, optimal disease ovarian cancer: a Southwest Oncology Group Study.
    Alberts DS; Mason-Liddil N; O'Toole RV; Abbott TM; Kronmal R; Hilgers RD; Surwit EA; Eyre HJ; Baker LH
    Gynecol Oncol; 1989 Jan; 32(1):16-21. PubMed ID: 2642453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stages III and IV suboptimal disease ovarian cancer: a Southwest Oncology Group Study.
    Alberts DS; Mason-Liddil N; O'Toole RV; Abbott TM; Kronmal R; Hilgers RD; Surwit EA; Eyre HJ; Baker LH
    Gynecol Oncol; 1989 Jan; 32(1):8-15. PubMed ID: 2642455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active specific immunotherapy in ovarian cancer.
    Crowther ME; Levin L; Poulton TA; Saffrey MJ; Curling OM; Hudson CN
    Recent Results Cancer Res; 1978; 68():166-73. PubMed ID: 752855
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: a Gynecologic Oncology Group study.
    Creasman WT; Omura GA; Brady MF; Yordan E; DiSaia PJ; Beecham J
    Gynecol Oncol; 1990 Dec; 39(3):239-43. PubMed ID: 2258063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic sensitivity of minimal residual disease following surgical excision of ovarian carcinoma.
    Edmonson JH; Fleming TR; Decker DG; Jorgensen EO; Malkasian GD; Jefferies JA; Kvols LK; Webb MJ
    Recent Results Cancer Res; 1978; 68():157-9. PubMed ID: 752853
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.
    Gutterman JU; Cardenas JO; Blumenschein GR; Hortobagyi G; Burgess MA; Livingston RB; Mavligit GM; Freireich EJ; Gottlieb JA; Hersh EM
    Br Med J; 1976 Nov; 2(6046):1222-5. PubMed ID: 791447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the therapeutic effects of adriamycin alone versus adriamycin plus vincristine versus adriamycin plus cyclophosphamide in the treatment of advanced carcinoma of the cervix.
    Wallace HJ; Hreshchyshyn MM; Wilbanks GD; Boronow RC; Fowler WC; Blessing JA
    Cancer Treat Rep; 1978 Oct; 62(10):1435-41. PubMed ID: 709549
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination chemoimmunotherapy for advanced renal carcinoma with Adriamycin, bleomycin, vincristine, cyclophosphamide, plus BCG.
    Dana BW; Alberts DS
    Cancer Clin Trials; 1981; 4(2):205-7. PubMed ID: 6166407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoimmunotherapy versus chemotherapy for remission induction in patients with non-Hodgkin's lymphoma: progress report of a Southwest Oncology Group study.
    Jones SE
    Recent Results Cancer Res; 1978; 65():164-9. PubMed ID: 85322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
    Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM
    Cancer; 1979 Apr; 43(4):1225-33. PubMed ID: 445325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancer.
    Buzdar AU; Gutterman JU; Blumenschein GR; Hortobagyi GN; Tashima CK; Smith TL; Hersh EM; Freireich EJ; Gehan EA
    Cancer; 1978 Mar; 41(3):1064-75. PubMed ID: 638948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic irradiation plus adriamycin and cyclophosphamide in selected patients with epithelial ovarian carcinoma: a phase II study of the Northern California Oncology Group.
    Ballon SC; Martinez A; Turbow MM; Koretz MM; Carter SK
    Gynecol Oncol; 1984 Nov; 19(3):278-83. PubMed ID: 6542049
    [No Abstract]   [Full Text] [Related]  

  • 15. A preliminary study of cyclophosphamide (NSC-26271), adriamycin (NSC-123127), imidazole carboxamide (NSC-45388), and actinomycin D (NSC-3053) with or without MER-BCG in patients with advanced sarcomas.
    Creagan ET; Edmonson JH; Hahn RG; Ahmann DL; Bisel HF; Eagan RT
    Med Pediatr Oncol; 1978; 4(1):85-6. PubMed ID: 625266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoimmunotherapy of small cell bronchogenic carcinoma.
    Holoye PY; Samuels ML; Smith T; Sinkovics JG
    Cancer; 1978 Jul; 42(1):34-40. PubMed ID: 208755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoimmunotherapy with or without oophorectomy in premenopausal patients with advanced breast cancer.
    Yap HY; Hortobagyi GN; Blumenschein GR; Tashima CK; Buzdar AU; Krutchik AN; Benjamin RS; Gutterman JU; Bodey GP
    J Surg Oncol; 1979 Dec; 12(4):333-41. PubMed ID: 392197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoimmunotherapy of sarcomatoid renal cell carcinoma.
    Krutchik AN; Sullivan C; Sinkovics JG; Ayala A
    Med Pediatr Oncol; 1978; 5(1):9-13. PubMed ID: 570634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adriamycin versus BCG in superficial bladder cancer: a Southwest Oncology Group Study.
    Lamm DL; Crissmann J; Blumenstein B; Crawford ED; Montie J; Scardino P; Grossman HB; Stanisic T; Smith J; Sullivan J
    Prog Clin Biol Res; 1989; 310():263-70. PubMed ID: 2672016
    [No Abstract]   [Full Text] [Related]  

  • 20. Ftorafur, adriamycin, cyclophosphamide and BCG in the treatment of metastatic breast cancer.
    Hortobagyi GN; Blumenschein GR; Tashima CK; Buzdar AU; Burgess MA; Livingston RB; Valdivieso M; Gutterman JU; Hersh EM; Bodey GP
    Cancer; 1979 Aug; 44(2):398-405. PubMed ID: 383255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.